US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,831.70

-3.5908-0.20%

Number of Gainers:2

Number of Losers:17

Number of Flat:- -

PE:- -

High:1,844.83

Open:1,843.77

Low:1,825.88

Close:1,835.29

Volume:94.13M

Turnover:5.53B

Market Cap:1.49T

Float Cap:1.46T

Loading ...

BioNTech Terminates Phase 2 Trial of Autogene Cevumeran in Colorectal Cancer

MT Newswires Live

Jefferies sees neutral to negative read-through to Alnylam from AstraZeneca data

Novavax’s partners approved for Nuvaxovid formulation for vaccination season

iBio Advances IBIO-600 into Phase 1 Multiple-Ascending-Dose Trial Stage After Completing Single-Ascending-Dose Dosing

Novavax's Partnership Strategy Continues to Deliver with Xfg-Adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season

THOMSON REUTERS

Novavax, - Eligible for Royalties on Net Sales in U.S., EU, Japan for 2026-2027 Season

THOMSON REUTERS

Argus Research Upgrades Moderna to Buy From Hold, $180 Price Target

MT Newswires Live

Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes

Moderna Price Target Announced at $180.00/Share by Argus Research

U.S. Stocks on the MOVE-Cytokinetics, Moderna, Ulta Beauty

Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough

Moderna Prices $2.6 Billion Convertible Notes due 2032

MT Newswires Live

Moderna Rises After Upsized $2.6 Bln Convertible Bond Sale

iBio FY26 Net Loss Widens to $33.04 Million; Revenue Drops to $100,000

Ibio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS

Press Release: iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update

Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push

Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares

Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV

U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/BK4568/news?page=11"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1831.6982,"timestamp":1789070399999,"preClose":1835.2891,"halted":0,"volume":94127665,"delay":0,"changeRate":-0.001957,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-3.59082,"latestTime":"09-10 16:00:00 EDT","open":1843.7695,"high":1844.8345,"low":1825.875,"amount":5530296282.364558,"amplitude":0.010331,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789113600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.81388,"peRate":46.873968,"turnoverRate":0.006785,"increases":2,"decrements":17,"flats":0,"marketCap":1489973728402,"floatMarketCap":1456164959030},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1844.8345,"amplitude":0.010331,"preClose":1835.2891,"low":1825.875,"pbRate":"4.81388","latestPrice":1831.6982,"volume":94127665,"delay":0,"open":1843.7695,"prevYearClose":1637.1339,"prevWeekClose":1896.2245,"prevMonthClose":1860.7577,"prevQuarterClose":1731.2963,"fiveDayClose":1903.6779,"twentyDayClose":1769.2863,"sixtyDayClose":1652.1289,"secType":"PLATE","market":"US","turnoverRate":0.006785,"peRate":46.873968,"marketCap":1489973728402,"floatMarketCap":1456164959030,"timestamp":1789070399999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":2,"down":17,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:11,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662309549","title":"BioNTech Terminates Phase 2 Trial of Autogene Cevumeran in Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662309549","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662309549?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:27","pubTimestamp":1787923675,"startTime":"0","endTime":"0","summary":"BioNTech Terminates Phase 2 Trial of Autogene Cevumeran in Colorectal Cancer","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4535","BNTX","BK4588","BK4551","BK4568","BK4548","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662093221","title":"Jefferies sees neutral to negative read-through to Alnylam from AstraZeneca data","url":"https://stock-news.laohu8.com/highlight/detail?id=2662093221","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662093221?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:50","pubTimestamp":1787921420,"startTime":"0","endTime":"0","summary":"After Ionis Pharmaceuticals (IONS) and AstraZeneca (AZN) presented full results of the Cardio-TTRansform trial at the ESC Congress 2026 in Munich, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jefferies-sees-neutral-to-negative-read-through-to-alnylam-from-astrazeneca-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jefferies-sees-neutral-to-negative-read-through-to-alnylam-from-astrazeneca-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","LU0289739699.SGD","IE00B3T34201.USD","LU2237443622.USD","LU0029864427.USD","LU2456880835.USD","BK4139","AZN","LU0320765992.SGD","BK4007","LU2237443895.HKD","LU2237443978.SGD","LU0432979614.USD","LU2089984988.USD","BK4585","AZNH","LU2237443465.HKD","LU2237443382.USD","BK4588","LU0889565916.HKD","LU0128525929.USD","LU0109394709.USD","LU2468319806.SGD","IONS","LU1267930573.SGD","LU2236285917.USD","LU0058720904.USD","LU0708994859.HKD","LU2237443549.SGD","LU2417539215.USD","LU0310800379.SGD","LU2462157665.USD","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662098045","title":"Novavax’s partners approved for Nuvaxovid formulation for vaccination season","url":"https://stock-news.laohu8.com/highlight/detail?id=2662098045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662098045?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:35","pubTimestamp":1787920541,"startTime":"0","endTime":"0","summary":"Novavax’s (NVAX) partners have received approvals for the Nuvaxovid formulation to target the SARS-CoV-2 XFG variant for the 2026-2027 vaccination ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novavaxs-partners-approved-for-nuvaxovid-formulation-for-vaccination-season-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novavaxs-partners-approved-for-nuvaxovid-formulation-for-vaccination-season-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVAX","BK4588","BK4585","BK4547","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662982530","title":"iBio Advances IBIO-600 into Phase 1 Multiple-Ascending-Dose Trial Stage After Completing Single-Ascending-Dose Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2662982530","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662982530?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:31","pubTimestamp":1787920308,"startTime":"0","endTime":"0","summary":"iBio advances IBIO-600 into Phase 1 multiple-ascending-dose trial stage after completing single-ascending-dose dosingiBio initiated a Phase 1 trial of IBIO-600 in fiscal 2026, moving the company into ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL26tsVp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBIO","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662098445","title":"Novavax's Partnership Strategy Continues to Deliver with Xfg-Adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season","url":"https://stock-news.laohu8.com/highlight/detail?id=2662098445","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662098445?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:30","pubTimestamp":1787920201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nTUA3TRSHN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4547","NVAX","BK4568","BK4585","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662098441","title":"Novavax, - Eligible for Royalties on Net Sales in U.S., EU, Japan for 2026-2027 Season","url":"https://stock-news.laohu8.com/highlight/detail?id=2662098441","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662098441?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:30","pubTimestamp":1787920201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nTUA3TRSHN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NVAX","BK4585","BK4547","BK4568","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662098660","title":"Argus Research Upgrades Moderna to Buy From Hold, $180 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2662098660","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662098660?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:20","pubTimestamp":1787919631,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) has an average rating of hold and mean price target of $96.47, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","BK4548","BK4588","MRNA","BK4585","GNOM","MRNX","IDNA","BK4551","MRNY","LGHT","WDNA","BK4568","BK4533","BK4534","BK4139","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662060019","title":"Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2662060019","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662060019?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:12","pubTimestamp":1787919133,"startTime":"0","endTime":"0","summary":"BRIEF-Moderna Announces Pricing Of Upsized $2.6 Billion Offering Of Convertible Senior NotesAug 28 -Moderna IncMRNA.O:MODERNA: MODERNA ANNOUNCES PRICING OF UPSIZED $2.6 BILLION OFFERING OF CONVERTIBLE SENIOR NOTESMODERNA: PURCHASED HEDGE OVERLAY INTENDED TO OFFSET DILUTION UP TO CAP INITIALLY EQUAL TO 175.0% PREMIUM TO STOCK PRICE AT PRICINGSource text: [ID:]Further company coverage:MRNA.O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44P0W5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4139","MRNX","BK4568","IDNA","BK4585","LGHT","MRNA","MRNY","BK4588","BK4533","BK4532","GNOM","WDNA","BK4548","BK4501","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662060438","title":"Moderna Price Target Announced at $180.00/Share by Argus Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2662060438","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662060438?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:00","pubTimestamp":1787918400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MRNA/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNOM","WDNA","BK4568","BK4139","BK4588","BK4548","LGHT","BK4534","MRNY","IDNA","MRNX","MRNA","BK4585","BK4532","BK4501","BK4551","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662677510","title":"U.S. Stocks on the MOVE-Cytokinetics, Moderna, Ulta Beauty","url":"https://stock-news.laohu8.com/highlight/detail?id=2662677510","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662677510?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:41","pubTimestamp":1787917296,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna, Ulta BeautyAugust 28 (Reuters)-Futures tied to the S&P 500 and Nasdaq inched lower on Friday after Nvidia's stellar forecast sparked a technology ra","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL6N44P0MR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061474960.USD","NVDX","CHAT","IE00BJJMRX11.SGD","LU1267930730.SGD","BK4139","MRNX","LU0210528500.USD","LU0316494557.USD","LU0823414478.USD","LU2471134952.CNY","LU0795875169.SGD","IREX","LU2361045086.USD","LU2420271590.USD","LU1064131342.USD","LU0072462426.USD","LU1935042991.SGD","LU1069344957.HKD","LU1720051017.SGD","NVIW.SI","SG9999015952.SGD","LU0726765562.USD","IE00B1BXHZ80.USD","LU2272731600.USD","LU0077335932.USD","LU0820561909.HKD","LU2238339852.HKD","LU0234570918.USD","SG9999014880.SGD","LU0417517546.SGD","BK4608","LU0124676726.USD","NVDO","LU1551013342.USD","FDTX","SHOC","BK4595","LU0965509283.SGD","LU1868837136.USD","IE00BWXC8680.SGD","LU2108987350.USD","LU2211815571.USD","LU1935042488.USD","DIPS","LTL","THMR","SOXQ","LU0788109477.HKD","LU2054465674.USD","LU1046421795.USD","LU0174119429.USD","LU0661504455.SGD","LU0345768740.USD","AFRU","LU0203202063.USD","LU0949170772.SGD","LU1267930490.SGD","LU2191332357.HKD","LU1202635105.USD","LU1814569148.SGD","LU2750360997.AUD","LU2271345857.HKD","LU0094547139.USD","FAI","LU0310799852.SGD","LU2077746001.SGD","LU2092937148.SGD","SG9999015978.USD","LU1127390331.HKD","LU0308772762.SGD","NVDQ","LU1791710400.SGD","CNEQ","NVDA","IREZ","LU0006306889.USD","LU1934455277.USD","SOXX","LU0127658192.USD","HK0000304805.HKD","IE0034235295.USD","IREN","LU2461242641.AUD","GNOM","LU1674673691.USD","CYTK","BK4561","BK4598","LU0689472784.USD","LU1242518931.SGD","MNRS","IE00BKPKM429.USD","TEK","LU0106831901.USD","LU0215105999.USD","ROM","LU0672654240.SGD","QNRX","BK4529","LU2506951792.HKD","BK4568","IE000YTNTUN2.SGD","LU0345770308.USD","07788","IPAY","LU0557290698.USD","LU2168564149.EUR","NVDY","LU1035775433.USD","BK4106","LU1242518857.USD","FTEC","SGXZ81514606.USD","IE00B19Z9Z06.USD","IE000Q6AESB8.SGD","LU0964807845.USD","LU2433249047.HKD","LU0472753341.HKD","ILDR","LU2023250330.USD","LU2458330169.SGD","LU0069063385.USD","LU2357125470.USD","BK4023","LU2462591350.SGD","WDNA","LU0353189763.USD","IE00BMPRXQ63.HKD","LU0823414551.USD","ADSK","LU0203201768.USD","LU2087621335.USD","SNVDAmain","LU1144417596.USD","LU2360032135.SGD","LU1119994496.HKD","LU0390134368.USD","IE00BD6J9T35.USD","BK4549","PYPL","BK4566","IE00B19Z8X17.USD","LU0323591593.USD","LFGY","LU0256863902.USD","NVD","LU1880398471.USD","ANV","PYPG","EFIV","LU2087625088.SGD","IE00BFSS7M15.SGD","LU2279689827.SGD","LU1366333091.USD","LU0211327993.USD","LU2381873111.SGD","WGMI","LU1868837300.USD","SG9999014914.USD","IE00BQXX3F31.USD","LU0912757837.SGD","LU1979441026.SGD","LU2430703178.SGD","LU1699723380.USD","LU0494093205.USD","NVDG","LU2452424414.USD","LU1983260115.SGD","LU2125910336.SGD","BK4524","IE00BK4W5M84.HKD","BK4085","LU1839511570.USD","BK4560","IE00BMPRXN33.USD","LU0128525929.USD","ARTY","BK4567","LU2491050154.USD","LU0823411888.USD","LU2860962120.EUR","LU1116320901.HKD","LU0787776722.HKD","IE00B4JS1V06.HKD","LU0426417589.USD","LU1803068979.SGD","IE00BN29S564.USD","LU2505996681.GBP","SG9999001424.SGD","LU1496350502.SGD","LGHT","LU0786609619.USD","LU0444973449.USD","IE00BK4W5L77.USD","LU2242650005.HKD","BK4501","LU2430703095.HKD","LU1366192091.USD","IE00B1XK9C88.USD","BK4585","USXF","LU1951200564.SGD","LU2931357623.SGD","LU2750360641.GBP","LU1712237335.SGD","LU2430703251.USD","LU1261432733.SGD","TTEQ","LU2237438978.USD","IE00BJTD4N35.SGD","LU0225283273.USD","CLSE","IE00BQXX3D17.EUR","LU2347655156.SGD","LU1066051225.USD","LU2063271972.USD","LU1145028129.USD","LU1323610961.USD","LU0175139822.USD","LU0689626769.HKD","LU1720051108.HKD","LU1923622291.USD","BNGE","HK0000914660.USD","LU2047632596.USD","SG9999014898.SGD","LU0011850046.USD","LU1989764664.SGD","LU0640476718.USD","LU2237443382.USD","LU1992135472.HKD","LU2100268510.USD","HK0000532082.HKD","BK4227","LU1923621640.USD","AIFD","LU2471134523.USD","LU1718418525.SGD","LU1400636491.USD","LU2083900584.USD","LU1923623000.USD","TRFK","RSPC","LU0345770993.USD","LU1935042215.USD","IE000KEQY171.SGD","NVII","LU1823568750.SGD","IE00BYXW3230.USD","BK4532","LU2746668461.USD","SG9999015341.SGD","IE00BHPRN162.USD","LU2272731865.HKD","NVDU","LU0943347566.SGD","LU1084165304.USD","LU1244550221.USD","LU2360107671.USD","BK4534","IE00BJTD4V19.USD","LU1934455863.HKD","LU0274383776.USD","LU1974910355.USD","LU1232071149.USD","IE0003U64NQ7.SGD","LU0823421333.USD","HK0000306685.HKD","LU0823421416.USD","GB00BDT5M118.USD","SOLS","LU0708995401.HKD","LU2361044865.SGD","IE0004086264.USD","BK4543","BITQ","LU2394011477.USD","LU0080751232.USD","LU2125909759.SGD","LU2326559502.SGD","LU1121112475.USD","LU1951198990.SGD","LU2089284900.SGD","HK0000320264.USD","BK4548","LU0251132253.USD","LU1914381329.SGD","LU2592432038.USD","DAPP","LU2487616109.SGD","LU1791807156.HKD","LU0170899867.USD","LU0347712357.USD","LU0957808578.USD","LU1668664300.SGD","LU1988902786.USD","LU0082616367.USD","LU1732800096.USD","LU2357305700.SGD","LU2403377893.USD","LU0109392836.USD","IE000ITXATA3.USD","VGT","LU0979878070.USD","LU0081259029.USD","LU2125909247.SGD","LU2237443549.SGD","NVDS.UK","LU0265550359.USD","LU0342679015.USD","LU2290526834.HKD","IE0009G5SDU7.USD","HK0000320223.HKD","IE0009356076.USD","LU1989764748.USD","LU2294711713.HKD","LU0056508442.USD","FDIG","IE00B19Z8W00.USD","IE0004445015.USD","LU0106261372.USD","LU1400636574.HKD","LU1992135399.USD","LU2168564065.EUR","LU0320765059.SGD","LU0353189680.USD","LU0133085943.USD","LU1267930573.SGD","LU2286300806.USD","LU1989772840.SGD","IE00BKVL7J92.USD","BK4109","HERO","LU1623119135.USD","ESPO","PYPY","LU0476273544.USD","IE00BZ199S13.USD","LU1548497426.USD","IE00BDRTCR15.USD","GAMR","IE00BJJMRY28.SGD","BKCH","IE0034235188.USD","LU0708994859.HKD","LU1153585028.USD","LU1815333072.USD","LU0511384066.AUD","SG9999014567.USD","CHPX","LU1861220207.SGD","LU1868836757.USD","LU2471134879.HKD","LU0444971666.USD","LATR","SG9999014906.USD","BK4094","LU0868494708.USD","IE00B4YYXB79.USD","LU2602419157.SGD","LU2361044949.HKD","LU2456880835.USD","LU2896262040.SGD","LU2125909916.SGD","LU0210536198.USD","LU1069347547.HKD","LU0345774391.USD","LU0882574139.USD","IE00BKDWB100.SGD","MRNA","LU1670756490.USD","BK4527","LU1804176565.USD","LU1935043023.USD","LU2247934214.USD","LU1633808545.USD","LU2148611432.USD","LU3102509885.SGD","NVC","LU0154236417.USD","LU0234572021.USD","NULC","LU2065171402.SGD","STBQ","STCE","LU1003077747.HKD","LU0354030438.USD","METV","LU1043141123.HKD","LU1169590202.USD","LU2491050071.SGD","LU0820561818.USD","SMHX","BTAI","LU0053666078.USD","XLC","BK4581","LU0823434583.USD","BK4587","AGOX","IE00B3M56506.USD","SG9999014575.USD","LU0683600562.USD","SG9999002224.SGD","LU1852331112.SGD","HK0000306701.USD","LU0466842654.USD","LU1037948541.HKD","LU2413666699.HKD","LU2272731782.SGD","SG9999017495.SGD","LU2298064838.USD","LU0323240290.USD","LU0823434740.USD","BK4592","IE00B775SV38.USD","LU1066053197.SGD","SGXZ80539844.SGD","LU1435385759.SGD","LU2097344431.USD","LU1429558221.USD","TTWO","LU0070217475.USD","ABFL","LU1989772923.USD","LU1116320737.USD","FINX","IE00BZ9MQY76.HKD","LU0157215616.USD","LU1280957306.USD","LU0138981039.USD","LU2746668974.SGD","LU2111349929.HKD","LU1923622614.USD","LU0310800379.SGD","LU0642271901.SGD","SG9999015358.SGD","LU1244550494.USD","IE00B775H168.HKD","SNVD.UK","LU2471134796.USD","GAP","LU0158827948.USD","LU0061474705.USD","XLK","LU2065169927.USD","NVDB","LU2322448957.HKD","SG9999000418.SGD","LU2264538146.SGD","LU2242649171.HKD","LU1732799900.SGD","SG9999018857.SGD","LU0868494617.USD","IE00B3S45H60.SGD","IE0005OL40V9.USD","LU0820562030.AUD","LU2125154935.USD","LU0965508806.USD","LU1803068623.USD","IE00B19Z9P08.USD","BK4097","IE00BJLML261.HKD","LU0210533765.USD","SGXZ51526630.SGD","LU1917777945.USD","IE00B894F039.SGD","LU0289960550.SGD","LU1571399168.USD","LU2552382132.HKD","LU0528227936.USD","BK4551","BK4535","LU2125154778.USD","LU0096362180.USD","AFRM","LU0158827781.USD","LU0323239441.USD","LU0238689110.USD","LU0724617625.USD","LU0029864427.USD","LU1642822529.SGD","LU0143551892.USD","IE00B5TLWC47.USD","IE0004445239.USD","BK4505","LU0079474960.USD","SGXZ23171101.USD","LU1066051811.HKD","LU2125910179.SGD","LU2347655073.USD","IE00B7KXQ091.USD","LU1037948897.HKD","BK4605","LU0057025933.USD","SG9999002232.USD","LU0289739343.SGD","IDNA","LU0345769128.USD","LU2023251221.USD","LU2360107168.USD","LU1169589451.USD","LU2552382215.SGD","LU0345774631.USD","LU2491049909.HKD","BK4533","LU0096364046.USD","LU1861220033.SGD","SGXZ99366536.SGD","MRNY","3NVD.UK","SG9999014542.SGD","LU0211328371.USD","LU1496350171.SGD","LU1815336760.USD","BK4600","LU2413666426.HKD","NVDS","IETC","LU2462591277.SGD","LU0965509101.SGD","LU2089283258.USD","BK4614","LU0738911758.USD","LU2133065610.SGD","IE0004091025.USD","07388","LU0048584097.USD","IE000W1ABFV2.USD","LU1235294995.USD","VT","LU0545039389.USD","SG9999015986.USD","SGXZ31699556.SGD","LU0345769631.USD","LU0942090050.USD","LU1880398554.USD","LU2463028550.USD","IBLC","LU2265009873.SGD","LU2543165471.USD","LU1861215975.USD","LU0107464264.USD","SG9999015945.SGD","LU0719512351.SGD","BK4588","LU2065171311.SGD","ESUM","BK4539","LU0097036916.USD","LU2417539215.USD","LU0985320562.USD","LU2237957811.SGD","LU2092627202.USD","LU2360106780.USD","LU1551013425.SGD","IE00B19Z9505.USD","LU2125909593.SGD","IE0001KFT4U8.USD","NVDD","LU1691799644.USD","LU1868836591.USD","LU1400636657.SGD","LU2999663052.SGD","TTXU","LU0289961442.SGD","LU0276348264.USD","PYPU","LU2237443465.HKD","TYLG","LU0266013472.USD","BK4612","IE00BZ1G4Q59.USD","BK4503","LU0553294199.USD","IE00BQXX3C00.GBP","LU1316542783.SGD","LU0965509010.AUD","LU2250418816.HKD","LU1939255532.USD","LU2236285917.USD","LU0957791311.USD","LU1244550577.SGD","LU1821325948.USD","LU2213496289.HKD","LU1629891620.HKD","ESLG","HK0000914686.HKD","LU0795875086.SGD","LU1861217088.USD","SG9999004303.SGD","AIPI","LU0109391861.USD","LU1035773651.USD","2NVD.UK","LU2322448791.USD","IE00B5949003.HKD","IE00B3SWFQ91.USD","LU1868836914.USD","LU2237443622.USD","LU0061475181.USD","NVDL","LU2237443895.HKD","LU0345768153.USD","LU2249611893.SGD","LU2756315318.SGD","SG9999014559.SGD","LU2168563687.JPY","LU0861579265.USD","IREG","LU2756315664.SGD","LU1043141396.HKD","LU1778281490.HKD","LU2505996509.AUD","LU2237957902.USD","LU1674673428.USD","BK4516","LU0994945656.USD","LU2473716301.USD","SPTE","NVD2.UK","SMH","LU0256863811.USD","LU2552382058.USD","IXN","LU2106854487.HKD","IE00BFSS8Q28.SGD","CMAG","LU0187121727.USD","ULTA","LU2637965513.SGD","IE00BMPRXR70.SGD","LU1935043536.SGD","LU0889565833.HKD","LU1066051498.USD","BK4579","LU0426412945.USD","IE0034235303.USD","SOXY","LU1721428933.USD","LU2458330243.SGD","IE00BDCRKT87.USD","SG9999018865.SGD","LU2168564222.USD","LU0348723411.USD","LU0395794307.EUR","LU1645745479.HKD","NVYY","LU0354030511.USD","BK4554","BK4550","LU0198837287.USD","LU2237443978.SGD","IREC","USD","WISE","LU0265550946.USD","NERD","HK0000819398.USD","JGRO","LU2462157665.USD","LU1791710582.SGD","S","LU2168564495.EUR","LU1861127337.USD","LU2954938101.SGD","LU2089985449.USD","LU0267386448.USD","BK4141","LU1934455194.USD","BK4200","HK0000304797.USD","NVD3.UK","BK4528","IRE","LU2028103732.USD","LU2244417387.USD","LU2065170008.USD","LU2023250504.SGD","LU2097344357.USD","SNPE","NVDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662667970","title":"Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough","url":"https://stock-news.laohu8.com/highlight/detail?id=2662667970","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662667970?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:30","pubTimestamp":1787916600,"startTime":"0","endTime":"0","summary":"An mRNA cancer vaccine Moderna had been developing with Merck had hit its mark — the first success of a therapeutic cancer vaccine in late-stage testing after more than 100 years of failed attempts.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44N0PO:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","IE00BSNM7G36.USD","LU1061106388.HKD","PPH","SG9999001176.SGD","SG9999014559.SGD","LU2324357040.USD","LU2023250843.SGD","LU1037948897.HKD","LU0689626769.HKD","LU1989771016.USD","IE00BJT1NW94.SGD","LU1923622614.USD","SG9999002232.USD","LU0965509010.AUD","LU1066051225.USD","LU1066051498.USD","BK4585","LU2106854487.HKD","LU0320765646.SGD","LU1116320901.HKD","LU2125909247.SGD","BK4532","XLV","LU2361044865.SGD","BK4588","LU1983299246.USD","GNOM","LU1699723380.USD","LU0965509101.SGD","LU0648001328.SGD","LU0965509283.SGD","IE00BN8TJ469.HKD","SG9999015358.SGD","IE00B2B36J28.USD","LU0238689110.USD","SG9999014567.USD","IHE","BK4534","BK4551","BK4548","LU2461242641.AUD","LU2491050154.USD","VHT","SG9999002224.SGD","LU0006306889.USD","IYH","LU2023250504.SGD","SG9999013999.USD","IE0002141913.USD","IE0009355771.USD","LU0477156953.USD","LU0203345920.USD","LU2491049909.HKD","BK4559","RXL","LU0985320562.USD","LU2361044949.HKD","LU1162221912.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","LU0265550359.USD","LGHT","LU1974910355.USD","LU2125909593.SGD","IE00BLSP4452.SGD","LU0289739699.SGD","LU0432979614.USD","LU1023059063.AUD","LU0124676726.USD","LU1929549753.HKD","LU1035773651.USD","BK4568","LU0106261372.USD","LU0942090050.USD","LU1934455194.USD","SG9999014575.USD","LU0122379950.USD","GDOC","LU0859254822.USD","LU0266013472.USD","LU1571399168.USD","LU0203347892.USD","IXJ","IE00BLSP4239.USD","LU1116320737.USD","SG9999001440.SGD","LU0070302665.USD","LU1941712264.USD","BMED","IE00BFTCPJ56.SGD","BK4516","BK4501","LU1057294990.SGD","LU1093756325.SGD","LU1989772840.SGD","LU2360032135.SGD","BK4139","LU0058720904.USD","LU1066051811.HKD","LU2089984988.USD","BK4007","LU2357627491.SGD","LU1941712348.USD","LU0265550946.USD","LU0130517989.USD","SG9999014542.SGD","LU0823416689.USD","LU1989772923.USD","LU1291159041.SGD","LU0130102774.USD","TRUH","LU0868494708.USD","WDNA","SGXZ57979304.SGD","LU1093756168.USD","FTXH","LU1934455863.HKD","LU0208291251.USD","SG9999015341.SGD","LU1201861249.SGD","LU0980610538.SGD","LU2125154935.USD","IDNA","LU0098860793.USD","LU0320765489.SGD","PAWZ","MRNA","MRK","LU0965508806.USD","LU2433249047.HKD","IE00BBT3K403.USD","IE00B1BXHZ80.USD","MRNX","LU2112291526.USD","HRTS","IE000M9KFDE8.USD","SG9999001176.USD","BK4550","BK4533","LU1430594728.SGD","LU1585245621.USD","LU0234572021.USD","LU1069347547.HKD","LU2491050071.SGD","LU2125154778.USD","LU1066053197.SGD","MRNY","LU0861579265.USD","LU2361045086.USD","LU1037948541.HKD","FHLC","IE00BJJMRZ35.SGD","LU0211331839.USD","LU1917777945.USD","LU1934455277.USD","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662389067","title":"Moderna Prices $2.6 Billion Convertible Notes due 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=2662389067","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662389067?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:23","pubTimestamp":1787916190,"startTime":"0","endTime":"0","summary":"Moderna  priced a $2.6 billion offering of convertible senior notes due 2032, up from the previously announced $2 billion, the company said Friday.Initial purchasers were granted an option to buy up to an additional $400 million of notes, the company said.The company expects to use the net proceeds to pay the cost of certain capped call transactions and for general corporate purposes, including potential investments in its oncology business and debt repayment, it added.The company expects the sale to initial purchasers to close Tuesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4501","LGHT","BK4532","WDNA","BK4548","BK4551","IDNA","GNOM","BK4139","BK4533","MRNY","BK4588","MRNX","BK4534","BK4568","MRNA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662062748","title":"Moderna Rises After Upsized $2.6 Bln Convertible Bond Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2662062748","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662062748?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:19","pubTimestamp":1787915947,"startTime":"0","endTime":"0","summary":"BUZZ-Moderna rises after upsized $2.6 bln convertible bond sale** Biotech firm Moderna'sMRNA.Oshares up 1.2% at $144.50 before the bell on Fri after it raises more capital than planned** Cambridge, Massachusetts-based MRNA announces pricing private offering of $2.6 bln 0% convertible bonds due March 1 2032** Conversion price of $210.58 represents 47.5% premium over stock's last close of $142.77** MRNA shares finished down 4.6% on Thurs after counveiled$2 bln offering for general corp purposes, including to grow its oncology business and repay debt** Co expects to use approx $285 mln of net proceeds to pay cost of capped call transactions; cap price of $392.62 is 175% above stock's last sale** On Aug 19, MRNA shares soared 177% to $174.38, a 3-1/2 year high, after co said itsskin cancer vaccine, combined with Merck'sMRK.NKeytruda, reduced risk of recurrence and spread of melanoma in a late-stage trial** Through Thurs, MRNA shares up 384% YTD** Avg rating of 23 analysts is \"hold\"; median","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL6N44P0MB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","BK4533","LGHT","MRNA","BK4568","GNOM","BK4585","BK4532","BK4139","BK4534","BK4501","IDNA","WDNA","BK4588","BK4551","BK4548","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662062588","title":"iBio FY26 Net Loss Widens to $33.04 Million; Revenue Drops to $100,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2662062588","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662062588?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:01","pubTimestamp":1787914880,"startTime":"0","endTime":"0","summary":"iBio FY26 net loss widens to $33.04 million; revenue drops to $100,000iBio posted fiscal 2026 revenue of USD 100,000, down 75%.Net loss widened to USD 33.04 million; loss per share narrowed to USD 0.3","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL91p7tC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","SG9999014013.SGD","IE00BQXX3D17.EUR","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00BN0W2W23.USD","SG9999014039.USD","LU0314104364.USD","IE00BQXX3F31.USD","NDAQ","IBIO","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","BK4588","BCDF","LU2210149790.SGD","LU2210150020.SGD","SG9999014021.USD","BK4585","BK4568","LU2095319765.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662879062","title":"Ibio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2662879062","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662879062?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:00","pubTimestamp":1787914801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nTUA2LSRYJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBIO","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662628570","title":"Press Release: iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2662628570","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662628570?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:00","pubTimestamp":1787914800,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Aug. 28, 2026  -- iBio, Inc. , a clinical-stage biotechnology company developing long-acting antibody therapeutics for obesity, cardiometabolic and cardiopulmonary diseases, today announced its financial results for the fiscal year ended June 30, 2026, and provided a corporate update on its progress.\"Fiscal year 2026 was a transformative year for iBio, most importantly marked by our transition to a clinical-stage company with the initiation of the Phase 1 clinical trial of IBIO-600, a potentially best-in-class, long-acting anti-myostatin monoclonal antibody designed to preserve muscle and improve body composition,\" said Martin Brenner, Ph.D., DVM, Chief Executive Officer and Chief Scientific Officer of iBio. \"Additional highlights came from our IBIO-610 program, where we presented preclinical data supporting its potential for fat-selective weight loss, complementing with current GLP-1 therapies by increasing fat loss while preserving lean mass, and to reduce weight regain fo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBIO","03160","BK4568","BK4588","BK4139","JDOC","TM","BK4099","BK4604","BK4555","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662762030","title":"Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2662762030","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662762030?lang=en_us&edition=fundamental","pubTime":"2026-08-28 10:17","pubTimestamp":1787883449,"startTime":"0","endTime":"0","summary":"Gilead breaks ground on Foster City biologics facility in $32 billion US investment pushGilead broke ground on its Chess biologics facility at its Foster City, California headquarters as part of a pla","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL98vB5b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","BK4578","LU2112291526.USD","IBBQ","TMED","LU0859254822.USD","IE00B19Z3581.USD","LU0320765992.SGD","LU0289739699.SGD","LU1674673691.USD","LU2357627491.SGD","LU0058720904.USD","GILD","LU2468319806.SGD","MEDI","LU1430594728.SGD","SG9999015952.SGD","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","LU0965509010.AUD","LU0861579265.USD","LU0965509101.SGD","BK4532","LU0823416689.USD","BK4568","LU1066051498.USD","IBB","LU0965508806.USD","LU0109394709.USD","LU0889565916.HKD","LU1934455863.HKD","LU2324357040.USD","LU1057294990.SGD","LU1066053197.SGD","LU1674673428.USD","LU2087621335.USD","BMED","LU1934455194.USD","IE0002270589.USD","LU1571399168.USD","BBH","BIB","TBXU","LU1037948897.HKD","BK4583","LU0965509283.SGD","BK4588","IE00BSNM7G36.USD","LU0234570918.USD","LU1037948541.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662394370","title":"Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662394370","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662394370?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:45","pubTimestamp":1787870729,"startTime":"0","endTime":"0","summary":"Gilead Sciences director Anthony Welters disposes of USD 2.64 million in common sharesGilead director Anthony Welters exercised stock options for 18,000 shares on Aug. 26, 2026 at prices of USD 60.67 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL29Bbzm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","LU0889565916.HKD","TMED","LU1839511570.USD","LU1585245621.USD","LU1061106388.HKD","BMED","LU0859254822.USD","BK4583","LU0109394709.USD","IE00B7SZLL34.SGD","LU2324357040.USD","IBBQ","BK4588","BIB","BK4585","IBB","LU2087621335.USD","LU2112291526.USD","BK4568","BK4566","BK4139","TBXU","LU0289739699.SGD","LU1571399168.USD","LU1674673428.USD","IE00B19Z3581.USD","LU0965509010.AUD","LU0965508806.USD","LU0823416689.USD","LU1430594728.SGD","IE00BSNM7G36.USD","BK4532","LU0861579265.USD","LU0965509101.SGD","GILD","LU0320765992.SGD","LU1057294990.SGD","SG9999015986.USD","LU1037948897.HKD","LU1023059063.AUD","LU1066051498.USD","IE00B19Z3B42.SGD","BK4578","LU0122379950.USD","IE00B3T34201.USD","LU0058720904.USD","MEDI","LU1934455863.HKD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036059","title":"Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036059","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036059?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:55","pubTimestamp":1787867719,"startTime":"0","endTime":"0","summary":"Gilead (GILD) Sciences announced that the FDA approved Bixlenvo – bictegravir 75 mg/lenacapavir 50 mg -, the smallest once-daily single tablet regi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gileads-bixlenvo-approved-by-fda-for-virologically-suppressed-adults-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gileads-bixlenvo-approved-by-fda-for-virologically-suppressed-adults-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMED","BK4532","BK4588","LU1839511570.USD","LU1934455863.HKD","BBH","LU1066053197.SGD","BK4566","LU0965509101.SGD","IBB","IE00BZ1G4Q59.USD","LU2087621335.USD","LU0122379950.USD","LU2357627491.SGD","GILD","SG9999015986.USD","BK4568","BK4139","IE00B19Z3B42.SGD","LABU","LU1571399168.USD","BK4585","BMED","LU0859254822.USD","TBXU","LU1061106388.HKD","BIB","IE00B19Z3581.USD","LU1585245621.USD","LU0965509283.SGD","BK4583","LU0889565916.HKD","LU1023059063.AUD","LU1057294990.SGD","LU0861579265.USD","LU1934455194.USD","LU0234570918.USD","IBBQ","IE00BSNM7G36.USD","LU1674673691.USD","LU0823416689.USD","LU2324357040.USD","SG9999015945.SGD","LU1066051498.USD","LU0058720904.USD","LU1674673428.USD","LU0109394709.USD","MEDI","LU1037948897.HKD","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036807","title":"U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036807","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036807?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:47","pubTimestamp":1787867220,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA7M9KZ1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1934455277.USD","IBBQ","BK4550","LU2089984988.USD","GILD","BIB","LU0861579265.USD","LU1934455863.HKD","TBXU","BMED","LU0882574055.USD","BK4588","LU1061106388.HKD","LU0965509010.AUD","LU2112291526.USD","SG9999015945.SGD","IE00B3T34201.USD","LU0823416689.USD","IE00BZ1G4Q59.USD","BK4566","LU2087621335.USD","SG9999015978.USD","LU1066051498.USD","LU0320765992.SGD","BK4578","LU1571399168.USD","LU1057294990.SGD","LU0289739699.SGD","MEDI","IE00B7SZLL34.SGD","LU1839511570.USD","TMED","LU1066053197.SGD","IBB","IE00BKVL7J92.USD","BK4532","LU1430594728.SGD","LU0234570918.USD","BK4568","LU0889565916.HKD","LU1778281490.HKD","LU1037948897.HKD","LU0109394709.USD","LU1934455194.USD","BBH","BK4583","LU2468319806.SGD","LU0965509283.SGD","IE00B19Z3B42.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":11,"totalSize":220,"code":"91000000","status":"200"}]}}